STAR Stock View

Strides Pharma Science Ltd
stock-view-header

₹ 508.1

icon 6.95 | 1.39
Market Cap ₹( Cr.)
45,898.13
Proj. P/E (x)
21.58
Proj. P/BV (x)
2.06
Proj. ROE (%)
9.40
Proj EV / EBITDA (x)
--
Proj. Revenue ( Cr.)
39,619.00

Stock View

HOLD

Last Updated On.
24-Sep-2023
 

The average score for Strides Pharma Science Ltd stands at 5 against 4, three months back.

Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche and pharmaceutical products. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.


Technical Data

50 DMA(₹)
455.61
100 DMA(₹)
427.85
200 DMA(₹)
373.47
52 Weeks Range
268.40     549.00

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required